This story was first published in digitalhealth.net
Ebola vaccine found to offer immunity
A study led by the Oxford Vaccine Group at the University of Oxford has tested a new Ebola vaccine which has been found to provide immunity for up to a year after immunisation.
During the study, healthy volunteers were given one vaccine dose, developed by Janssen Vaccines & Prevention B.V. based on Janssen’s AdVac technology and MVA-BN technology from Bavarian Nordic A/S, to prime their immune system, and the alternative vaccine to boost their immune response.
Commenting on the findings, Dr Matthew Snape from the Department of Paediatrics at Oxford, who led the research, said: “The persistence of vaccine-induced immunity to one year post-immunisation is truly impressive.
“The fact that all participants retained Ebola-specific antibodies to the end of the study does raise hope that this vaccine could induce responses that last for several years.
“This study was conducted in a European population, so it’s important to note that immune responses may differ in a sub-Saharan African population, but these vaccine candidates are currently being assessed in this region.
“Additional research is also needed to explore the persistence of immunity beyond the one year mark and the response to booster doses of vaccine.”
Latest News
16/02/2024 - 12:56
Hammersmith and Fulham Council has created a new alliance intended to clean dirty air and improve residents' health.
16/02/2024 - 10:44
Two million more GP appointments a month are being delivered for patients compared to the same month before the pandemic as part of the NHS primary care access recovery plan according to new NHS data.
15/02/2024 - 10:26
The Welsh Government has provided innovation funding of £380,000 to support two projects utilising technology in domiciliary care.
15/02/2024 - 10:13
The new Scottish health secretary has met with frontline staff at Queen Elizabeth University Hospital in Glasgow.
14/02/2024 - 10:27
The North East London NHS Foundation Trust (NELFT) has appointed three new Executive Directors to the Trust Board.
Product Features
UK Building Regulations highlight toxic gas and smoke from layers of paint built up over multiple redecorations as a major cause of permanent ill health or death in a building fire.
Their concern rose with discovery the flame retardant paints most widely used paint along escape routes have been ones which to this day counter-productively use emission of heavy toxic gas to smother flames which rapidly spread along walls if layers of paint delaminate in a fire.
Supplier Profiles
Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients
Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho
Latest Features
Sarah Greenslade, public affairs and communications officer at the British Parking Association looks at some of the problems and innovations in healthcare parking
It’s easy to assume that the comms team is there to handle press enquiries and the occasional social media storm – but the reality is that strategic communications can make a measurable impact across the entire organisation, from operational to financial, when done properly
